P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
5,251.50
57.75 (1.11%)
BSENSE

Feb 09

BSE+NSE Vol: 24.17 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Standalone Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 14.38% vs 4.57% in Dec 2024

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 22.26% vs 3.15% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 12.37% vs 10.85% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is -32.00% vs -3.85% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024

Compare Nine Monthly Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,037.52
416.74
620.78
148.96%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,037.52
416.74
620.78
148.96%
Raw Material Cost
222.14
191.59
30.55
15.95%
Purchase of Finished goods
48.27
5.44
42.83
787.32%
(Increase) / Decrease In Stocks
1.80
-9.20
11.00
119.57%
Employee Cost
171.70
69.04
102.66
148.70%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
1.25
-1.25
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
272.54
92.96
179.58
193.18%
Total Expenditure (Excl Depreciation)
716.45
351.08
365.37
104.07%
Operating Profit (PBDIT) excl Other Income
321.07
65.66
255.41
388.99%
Other Income
13.34
39.52
-26.18
-66.24%
Operating Profit (PBDIT)
334.41
105.18
229.23
217.94%
Interest
0.34
5.47
-5.13
-93.78%
Exceptional Items
0.00
-44.21
44.21
100.00%
Gross Profit (PBDT)
334.07
55.50
278.57
501.93%
Depreciation
17.42
35.77
-18.35
-51.30%
Profit Before Tax
316.65
19.73
296.92
1,504.92%
Tax
84.34
13.36
70.98
531.29%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
232.31
6.37
225.94
3,546.94%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
232.31
6.37
225.94
3,546.94%
Equity Capital
16.60
87.22
-70.62
-80.97%
Face Value
10.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.00
0.00
0.00
Operating Profit Margin (Excl OI)
30.95%
15.76%
0.00
15.19%
Gross Profit Margin
32.20%
13.32%
0.00
18.88%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 1,037.52 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 14.38% vs 4.57% in Dec 2024

Nine Monthly - Standalone Net Profit
Standalone Net Profit 232.31 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 22.26% vs 3.15% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 321.07 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 12.37% vs 10.85% in Dec 2024

Nine Monthly - Interest
Interest 0.34 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -32.00% vs -3.85% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.95%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024